Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Immunotherapy
Prostate Cancer
Ovarian Cancer
Chronic Lymphocytic Leukemia
PARP Inhibitors
Diffuse Large B-Cell Lymphoma
Endometrial Cancer
Gastroesophageal Cancer
Multiple Myeloma
Clinical Trials
Non-Hodgkin Lymphoma
Bispecific Antibodies
Pembrolizumab
Breast Cancer
Venetoclax
Urothelial Bladder Cancer
Colorectal Cancer
BTK Inhibitors
Follicular Lymphoma
Endocrine Therapy

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes552Founded7 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Featuring an interview with Dr Matthew Lunning, including the following topics:

• Tafasitamab for follicular lymphoma (0:00)

• frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)

CME information and... more

YouTube

Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:

• Introduction (0:00)

• Prologue: Saturday Night Fever (1:35)

• Baby Boomers' Guide to Mechanisms of Action (3:07)

• Second-Line Treatment (12:36)

• C... more

YouTube

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:

• Multiple Myeloma (0:00)

• Introduction: ESMO 2026; Recent FDA Approvals (1:53)

• Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)

• Bi... more

YouTube

Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics:

• Introduction: ESMO 2026; Recent FDA Approvals (0:00)

• Selection of Endocrine Therapy — Dr Antonarakis (2:24)

• Utility of PARP Inhibitors... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Chan Cheah
Clinical investigator at Sir Charles Gairdner Hospital
Sir Charles Gairdner Hospital
Episode: Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies
Matthew Matasar
Clinical investigator at Rutgers Cancer Institute
Rutgers Cancer Institute
Episode: Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies
Sagar Lonial
Myeloma specialist at the Winship Cancer Institute of Emory University
Winship Cancer Institute
Episode: Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Paul G. Richardson
Myeloma specialist at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Matthew Lunning
Medical oncologist and clinical investigator
Fred and Pamela Buffett Cancer Center
Episode: Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens
Erica Mayer
Medical oncologist at Dana-Farber Cancer Institute specializing in breast cancer
Dana-Farber Cancer Institute
Episode: Hormone Receptor-Positive Localized Breast Cancer — A Grand Rounds Activity
Lindsey Roeker
Clinical investigator at Mayo Clinic
Mayo Clinic
Episode: Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6
Daniel Erman
Clinical investigator at the University of Utah Huntsman Cancer Institute
Huntsman Cancer Institute
Episode: Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6
Shazia Nakoda
Clinical investigator at Fox Chase Cancer Center
Fox Chase Cancer Center
Episode: Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6

Host

Neil Love
Medical oncologist and president and director of Research To Practice

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#123
Norway/Science
Apple Podcasts
#128
South Korea/Science
Apple Podcasts
#159
Hong Kong/Science
Apple Podcasts
#178
Saudi Arabia/Science
Apple Podcasts
#213
Denmark/Science
Apple Podcasts
#228
Brazil/Science

Talking Points

Recent interactions between the hosts and their guests.

Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies
Q: Can you go to CAR T right after [bispecifics]? Should you put something in between it in terms of sequencing?
Matasar says there is not enough evidence to establish an ideal sequence. In follicular lymphoma, neither approach is clearly curative, and many clinicians currently prioritize bispecifics while reserving CAR T-cell therapy for selected patients, including those with suspected transformation.
Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies
Q: Any thoughts about where we are right now and where we're going to be after ASH in particular?
Matthew Matasar says bispecific antibodies are becoming central options in second-line follicular lymphoma care, with trials comparing combinations and schedules likely to clarify their benefits and practical tradeoffs.
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 1: An Interview with Dr Matthew Lunning on CNS Prophylaxis
Q: What about R-pola-mini-CHP? Is that something that you utilize?
Lunning describes discussing the regimen for older patients with comorbidities. It uses full-dose polatuzumab with mini-R-CHP, and he notes that clinicians may initially give the CHP portion while assessing how well a hospitalized patient can tolerate treatment.
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 1: An Interview with Dr Matthew Lunning on CNS Prophylaxis
Q: How do you think about better identifying who's at risk, and what about ctDNA in the CSF?
Lunning recommends starting with CNS symptoms and examination, using imaging when clinically indicated, and considering CNS risk factors such as extranodal disease and adrenal or renal involvement. He sees CSF ctDNA testing as an emerging approach best pursued through clinical trials while its use is evaluated.
Diffuse Large B-Cell Lymphoma — A Grand Rounds Program
Q: Where would you use sur ovatamig in diffuse large B-cell lymphoma, and how early would you use it?
Matasar describes a potential use after first-line treatment, CAR T-cell therapy, and a CD20-targeting bispecific, if the lymphoma later loses CD20 but remains CD19-positive. He says CD19-directed treatment could address antigen escape while engaging T cells through a different target.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

Clinical investigators and practicing oncologists discuss new cancer research and how it may shape treatment decisions in general medical oncology. Medical oncologist Neil Love leads interviews, journal-club discussions, case reviews and conference-session conversations, with recurring attention to trial evidence, patient characteristics, treatment sequencing, toxicity and the limits of emerging data. Topics span breast, ovarian, prostate and lung cancers, as well as chronic lymphocytic leukemia and multiple myeloma. Guests include specialists who present research alongside practical guidance, often using patient cases to show how evidence informs choices in different clinical settings. The format suits oncology professionals seeking concis... more

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Oncology Brothers: Practice-Changing Cancer Discussions
2. Two Onc Docs
3. Research To Practice | Oncology Videos
4. Breast Cancer Update
5. OncLive® On Air

How many episodes of Oncology Today are there?

Oncology Today launched 7 years ago and published 552 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Chan Cheah
2. Matthew Matasar
3. Sagar Lonial
4. Paul G. Richardson
5. Matthew Lunning
6. Erica Mayer
7. Lindsey Roeker
8. Daniel Erman

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days